Skip to content
Review Open access

Pancreatic islets: new discoveries for innovative treatments of diabetes?

Aug 2026 · Diabetologia · 0 citations · 67 references
Medicine

TL;DR

This review has selected recent examples that highlight the progress made in understanding human islets and beta cell biology, and questioned why there is still a gap in knowledge regarding beta cell destruction in type 1 diabetes, despite hundreds of thousands of published studies.

Abstract

Pancreatic beta cells are dedicated factories in the production, storage and secretion of impressive amounts of insulin. In the human pancreas, beta cells are found in clusters known as islets of Langerhans which vary in cell quantity and endocrine cell types, including glucagon-producing alpha cells and somatostatin-producing delta cells. Major progress has been made in recent years in understanding beta cell physiology and pathology, with a particular focus on the mechanisms of beta cell destruction in type 1 diabetes and potential approaches for restoring beta cell function. In this review, we have selected recent examples that highlight the progress made in understanding human islets and beta cell biology. Specifically, we (1) concentrated on new discoveries in beta cells, both within and outside of the islets of Langerhans; (2) evaluated whether more understanding of basic beta cell biology is needed; (3) discussed whether more tools are needed to provide answers to our key questions; as an example, we highlighted the progress made in the development of human beta cell lines and in the imaging tools for studying human beta cells; (4) questioned why there is still a gap in knowledge regarding beta cell destruction in type 1 diabetes, despite hundreds of thousands of published studies. We conclude with our vision of beta and islet cell biology.

Read PDF

Similar papers

Review Open access Oct 2026

BIOTECHNOLOGICAL ROUTES FOR INSULIN PRODUCTION

Insulin is a peptide hormone produced by β-cells of the Islets of Langerhans in the pancreas and plays a central role in regulating blood glucose homeostasis. Historically, insulin therapy relied on extraction from animal pancreases, but this approach was limited by supply constraints, variable purity, and immunogenic...

Lutfi Asani · 0 citations
Review Open access Oct 2026

Beta-cell replacement for type 1 diabetes: integrating cell products, engraftment and immune protection

Beta-cell replacement aims to restore endogenous, glucose-responsive insulin secretion in type 1 diabetes. Donor-islet transplantation has shown that this approach can improve glycaemic control and prevent severe hypoglycaemia. Its wider use is limited by donor supply, early graft loss and chronic systemic immunosuppre...

Lan Chen, Xin-Hao Hu, Chen Zheng et al. · 0 citations
Review Sep 2026

[Type 1 diabetes, towards new horizons].

Madeleine Wéra, Juliette Rulmont, N. Paquot et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.